HHS wants your comments on antiviral use for flu pandemic
The feds have issued two guidances related to the use of drugs for the influenza pandemic.
The Department of Health & Human Services has issued two proposed guidances about the use of drugs during an influenza pandemic. One relates to antiviral drugs < http://aspe.hhs.gov/panflu/antiviraluse.html>, the other is about antiviral drug stockpiling by employers in preparation for an influenza pandemic. HHS is now interested in receiving comments about the two documents. Deadline for comments is July 3. In a response to the proposal, Trust for America’s Health, a nonprofit group whose mission is to protect the health of every community, said that it is unreasonable for the government to expect businesses and individuals to shoulder the costs of a pandemic outbreak without the assurance of equal access to key prevention strategies, like antivirals.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
